Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when HAIN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Closing Condition Not Satisfied (new) — The International Business Transaction did not close because the required credit agreement amendment was not completed by October 12, 2026.
- Lender Discussions On Capital Structure (new) — The company is in discussions with lenders regarding its capital structure, indicating potential financial stress or restructuring.
Hain Celestial's International sale to AURELIUS misses key closing condition; talks continue
Filed October 15, 2026 · Period ending October 9, 2026 · ~1 min read
Key Changes
-
high
The planned sale of Hain Celestial's International business to AURELIUS did not close because a required credit agreement amendment was not completed by October 12, 2026.
Item 8.01 verify on EDGAR → -
high
The company remains in discussions with AURELIUS and is pursuing a path forward to complete the transaction.
Item 8.01 verify on EDGAR → -
high
Hain Celestial is also in discussions with its lenders regarding its capital structure and evaluating all available paths.
Item 8.01 verify on EDGAR → -
medium
The Board appointed Patricia Ferrari and Richard Shinder as new independent directors, effective immediately.
Item 5.02 verify on EDGAR → -
medium
Directors Shervin J. Korangy and Carlyn R. Taylor resigned effective October 9, 2026; the company states neither resignation resulted from any disagreement.
Item 5.02 verify on EDGAR →
Summary
Hain Celestial's planned sale of its International business to AURELIUS has hit a snag. The deal was conditioned on amending the company's credit agreement by October 12, 2026, but that condition was not met, so the transaction has not closed. The company says it remains in discussions with AURELIUS and is pursuing a path forward to complete the sale.
Separately, Hain Celestial is talking with its lenders about its capital structure, though the filing does not specify what changes are being discussed. These developments raise concerns about the company's ability to complete the divestiture and manage its debt obligations. In board changes, Hain Celestial appointed Patricia Ferrari and Richard Shinder as new independent directors, effective immediately.
They will receive a monthly cash fee of $30,000. The company also disclosed the resignations of Shervin J. Korangy and Carlyn R. Taylor, effective October 9, 2026. The filing states neither resignation resulted from any disagreement with the company. Mr. Korangy left to become CEO of Fresenius Medical Care, and Ms. Taylor left due to other professional commitments. For investors, the missed closing condition on the International sale is the key concern. The company's ongoing lender discussions about capital structure add uncertainty. The board changes appear routine, but the timing alongside the transaction issues may warrant attention.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Hain Celestial appoints two new independent directors and discloses two director resignations, effective immediately.
Added in current filing · verify on EDGAR →
the Board of Directors (the “Board”) of The Hain Celestial Group, Inc. (“Hain Celestial” or the “Company”) appointed Patricia Ferrari and Richard Shinder as new directors, effective immediately.
The Board added two new independent directors, Patricia Ferrari and Richard Shinder, effective immediately. Ms. Ferrari joins the Compensation and Strategy Committees, and Mr. Shinder joins the Audit and Strategy Committees. Both were determined to be independent under Nasdaq and SEC rules.
Added in current filing · verify on EDGAR →
the resignations of Shervin J. Korangy and Carlyn R. Taylor from the Board, each of whom tendered their resignations on October 9, 2026, effective immediately.
Two directors resigned effective immediately. Mr. Korangy left due to his appointment as CEO of Fresenius Medical Care, and Ms. Taylor left due to other professional commitments, including her role as CEO of Sirva. The filing states neither resignation resulted from any disagreement with the Company.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
each will receive a monthly cash fee of $30,000
Each new non-employee director will receive a monthly cash fee of $30,000 under an engagement letter, plus the Company's standard indemnification agreement. This is a straightforward compensation disclosure for the new board members.
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Closing of the International Business Transaction is subject to certain conditions, including the Company and its lenders entering into an amendment of the Company’s credit agreement by October 12, 2026. This condition was not satisfied; however, the Company has been engaged in discussions with AURELIUS and continues to pursue a path forward for completing the International Business Transaction.
The sale of Hain Celestial's International business to AURELIUS-affiliated purchasers was conditioned on amending the Company's credit agreement by October 12, 2026. That condition was not met, so the transaction has not closed. The Company says it is still in discussions with AURELIUS and pursuing a path to complete the deal.
Added in current filing · verify on EDGAR →
The Company also remains in discussions with its lenders regarding its capital structure and continues to evaluate and pursue all available paths.
Beyond the AURELIUS transaction, Hain Celestial is actively talking with its lenders about its capital structure. The filing does not specify what changes are being discussed, but the language suggests the company is working to address its debt or financing arrangements.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 16, 2026 · How we verify